Semler Scientific/$SMLR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Semler Scientific
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.
Ticker
$SMLR
Sector
Primary listing
Employees
79
Headquarters
Website
SMLR Metrics
BasicAdvanced
$363M
6.08
$3.94
1.40
-
Price and volume
Market cap
$363M
Beta
1.4
52-week high
$81.56
52-week low
$21.84
Average daily volume
1.1M
Financial strength
Current ratio
0.596
Quick ratio
0.444
Long term debt to equity
25.105
Total debt to equity
25.105
Interest coverage (TTM)
2.67%
Profitability
EBITDA (TTM)
5.254
Gross margin (TTM)
90.84%
Net profit margin (TTM)
86.20%
Operating margin (TTM)
12.10%
Effective tax rate (TTM)
17.02%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
1.07%
Return on equity (TTM)
16.04%
Valuation
Price to earnings (TTM)
6.08
Price to revenue (TTM)
5.071
Price to book
0.86
Price to tangible book (TTM)
0.86
Price to free cash flow (TTM)
17.896
Free cash flow yield (TTM)
5.59%
Free cash flow per share (TTM)
1.338
Growth
Revenue change (TTM)
-30.39%
Earnings per share change (TTM)
94.26%
3-year revenue growth (CAGR)
-7.54%
10-year revenue growth (CAGR)
25.44%
3-year earnings per share growth (CAGR)
34.48%
10-year earnings per share growth (CAGR)
13.39%
What the Analysts think about SMLR
Analyst ratings (Buy, Hold, Sell) for Semler Scientific stock.
Bulls say / Bears say
Q2 2025 net income of $66.9 M or $5.04 per diluted share was driven by an $83.8 M unrealized gain on Bitcoin, marking a significant turnaround from a $64.7 M Q1 loss and underscoring the material impact of its crypto treasury strategy. (Investing.com)
Semler’s Bitcoin holdings reached 5,021 BTC valued at $586.2 M as of July 31 2025, delivering a year-to-date 31.3% Bitcoin yield and validating its capital allocation approach. (PR Newswire)
The company raised $100 M through convertible senior notes and approximately $320 M net proceeds from ATM equity offerings by July 31 2025, providing ample liquidity to fund Bitcoin purchases without incurring debt. (PR Newswire)
Healthcare segment revenues declined 43.2% year-over-year to $8.2 M in Q2 2025 due to CMS reimbursement cuts, reflecting persistent headwinds and diminished core business sustainability. (Investing.com)
Operating expenses in Q1 2025 surged to $39.9 M (452% of revenues), driven by a $29.8 M DOJ settlement liability, severely straining cash flow and operational leverage in its healthcare business. (SEC)
Preliminary Q3 2025 guidance projects revenues of $6.9–7.5 M versus operating expenses of $12.8–13.4 M, indicating continued core segment losses and reliance on Bitcoin yields to fund operations. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2025.
SMLR Financial Performance
Revenues and expenses
SMLR Earnings Performance
Company profitability
SMLR News
AllArticlesVideos
SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR
Business Wire1 week ago
Deadline Soon: Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Business Wire1 week ago
SMLR 36 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025
Business Wire1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Semler Scientific stock?
Semler Scientific (SMLR) has a market cap of $363M as of November 05, 2025.
What is the P/E ratio for Semler Scientific stock?
The price to earnings (P/E) ratio for Semler Scientific (SMLR) stock is 6.08 as of November 05, 2025.
Does Semler Scientific stock pay dividends?
No, Semler Scientific (SMLR) stock does not pay dividends to its shareholders as of November 05, 2025.
When is the next Semler Scientific dividend payment date?
Semler Scientific (SMLR) stock does not pay dividends to its shareholders.
What is the beta indicator for Semler Scientific?
Semler Scientific (SMLR) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.